bupivacaine · Innocoll · NDA 204803
Posimir
Earliest generic entry, as listed
12 Jan 2041
No marketed reference-listed strength; date taken from all listed strengths.
Blocked by patent: US 11400019, US 11771624.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11400019 | product | 12 Jan 2041 |
| US 11771624 | use U-3724 | 12 Jan 2041 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 204803 · 001 · RLD · discontinued | solution, infiltration | 660MG/5ML (132MG/ML) | 12 Jan 2041 |